Zhongren Ding

2.2k total citations · 1 hit paper
40 papers, 1.6k citations indexed

About

Zhongren Ding is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Hematology. According to data from OpenAlex, Zhongren Ding has authored 40 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 13 papers in Hematology. Recurrent topics in Zhongren Ding's work include Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Platelet Disorders and Treatments (12 papers) and Adenosine and Purinergic Signaling (6 papers). Zhongren Ding is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Platelet Disorders and Treatments (12 papers) and Adenosine and Purinergic Signaling (6 papers). Zhongren Ding collaborates with scholars based in China, United States and South Korea. Zhongren Ding's co-authors include Satya P. Kunapuli, Si Zhang, Liang Hu, Soochong Kim, Robert T. Dorsam, Shenghui Zhang, Jianguo Jin, Yangyang Liu, Jianzeng Dong and Zhichao Fan and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

Zhongren Ding

39 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19

2020 474 citations Si Zhang, Yangyang Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhongren Ding China	18	462	386	357	289	245	40	1.6k
Marta Brambilla Italy	24	362 0.8×	424 1.1×	186 0.5×	397 1.4×	222 0.9×	78	1.8k
Mohammad Zahid Ashraf India	22	160 0.3×	546 1.4×	107 0.3×	156 0.5×	188 0.8×	50	1.4k
Zengxiang Dong China	22	289 0.6×	691 1.8×	63 0.2×	115 0.4×	105 0.4×	67	1.5k
Hirofumi Tomita Japan	27	1.2k 2.6×	511 1.3×	29 0.1×	89 0.3×	222 0.9×	187	2.2k
Paul C. Armstrong United Kingdom	23	543 1.2×	234 0.6×	28 0.1×	369 1.3×	219 0.9×	50	1.4k
Rozenn Quarck Belgium	26	604 1.3×	702 1.8×	33 0.1×	71 0.2×	424 1.7×	69	2.5k
Nirmal Parajuli Canada	25	754 1.6×	791 2.0×	279 0.8×	74 0.3×	352 1.4×	44	2.1k
Sonia Eligini Italy	26	381 0.8×	523 1.4×	35 0.1×	148 0.5×	524 2.1×	75	2.0k
Anna Klinke Germany	22	493 1.1×	410 1.1×	30 0.1×	82 0.3×	191 0.8×	59	1.9k
Órla P. Barry Ireland	14	229 0.5×	965 2.5×	31 0.1×	437 1.5×	131 0.5×	21	1.9k

Countries citing papers authored by Zhongren Ding

Since Specialization

Citations

This map shows the geographic impact of Zhongren Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongren Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongren Ding more than expected).

Fields of papers citing papers by Zhongren Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhongren Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongren Ding. The network helps show where Zhongren Ding may publish in the future.

Co-authorship network of co-authors of Zhongren Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Zhongren Ding. A scholar is included among the top collaborators of Zhongren Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhongren Ding. Zhongren Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Xiaowen, Qian Liu, Yangyang Liu, et al.. (2025). Endoplasmic Reticulum Stress‐Induced triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Downregulation Exacerbates Platelet Activation and Myocardial Infarction in Patients With Coronary Artery Disease. Journal of the American Heart Association. 14(13). e041220–e041220.

Chen, Cao, Qingyuan Yang, Xiaoshuang Xia, et al.. (2024). WY-14643, a novel antiplatelet and antithrombotic agent targeting the GPIbα receptor. Thrombosis Research. 238. 41–51. 2 indexed citations

Yang, Jing, Yangyang Liu, Zhiyong Qi, et al.. (2022). Galectin 3 enhances platelet aggregation and thrombosis via Dectin-1 activation: a translational study. European Heart Journal. 43(37). 3556–3574. 32 indexed citations

Yan, Rong, Ningbo Pang, Bin Cheng, et al.. (2021). Essential role of zyxin in platelet biogenesis and glycoprotein Ib-IX surface expression. Cell Death and Disease. 12(11). 955–955. 4 indexed citations

Zhong, Haoxuan, Wei Zhang, Liping Han, et al.. (2021). NOD2-mediated P2Y12 upregulation increases platelet activation and thrombosis in sepsis. Biochemical Pharmacology. 194. 114822–114822. 15 indexed citations

Li, Xiaowei, Xiaoxu Tian, Ying Peng, et al.. (2021). Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation. Stem Cell Research. 58. 102622–102622. 1 indexed citations

Liu, Yangyang, Xiaowei Li, Mengduan Liu, et al.. (2021). An induced pluripotent stem cells line (ZZUNEUi022-A) derived from urine cells of healthy male human. Stem Cell Research. 51. 102191–102191. 7 indexed citations

Wang, Lu, Xiaowei Li, Shuai Zhang, et al.. (2020). Generation of an IPSC line from a patient with hypertrophic cardiomyopathy carrying a mutation in MYH6 gene. Stem Cell Research. 50. 102138–102138. 3 indexed citations

Li, Xiaowei, Jiaxiang Wang, Mengduan Liu, et al.. (2020). An integration-free iPSC line ZZUNEUi008-A derived from dermal fibroblasts of a child with cardiac valvular dysplasia carrying a mutation in FLNA gene. Stem Cell Research. 47. 101882–101882. 2 indexed citations

10.

Chang, Lin, Jianjun Zhang, Yangyang Liu, et al.. (2020). GSK669, a NOD2 receptor antagonist, inhibits thrombosis and oxidative stress via targeting platelet GPVI. Biochemical Pharmacology. 183. 114315–114315. 19 indexed citations

11.

Wang, Mengyu, Yangyang Liu, Mengduan Liu, et al.. (2020). Induced pluripotent stem cell line (ZZUNEUi011-A) derived from peripheral blood mononuclear cells (PBMCs) of a healthy 27-year-old female individual. Stem Cell Research. 50. 102139–102139. 5 indexed citations

12.

Liu, Lei, Jian Li, Yan Zhang, et al.. (2014). Salvianolic acid B inhibits platelets as a P2Y12 antagonist and PDE inhibitor: Evidence from clinic to laboratory. Thrombosis Research. 134(4). 866–876. 47 indexed citations

13.

Liu, Guo‐Cheng, Jiaxi Xu, Ning Chen, et al.. (2012). Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents. European Journal of Medicinal Chemistry. 53. 114–123. 17 indexed citations

14.

Wei, Xunbin, Jianqin Ye, Guangda Liu, et al.. (2012). BF066, a Novel Dual Target Antiplatelet Agent without Significant Bleeding. PLoS ONE. 7(7). e40451–e40451. 16 indexed citations

15.

Hu, Liang, Zhichao Fan, Hongguang Du, et al.. (2011). BF061, a novel antiplatelet and antithrombotic agent targeting P2Y12 receptor and phosphodiesterase. Thrombosis and Haemostasis. 106(12). 1203–1214. 28 indexed citations

16.

Liu, Guo‐Cheng, Jiaxi Xu, Ki Chul Park, et al.. (2011). Novel synthesis approach and antiplatelet activity evaluation of 6-alkylamino-2,4-dialkyl(aryl)thiopyrimidines. Tetrahedron. 67(29). 5156–5161. 11 indexed citations

17.

Zhang, Si, Liang Hu, Hongguang Du, et al.. (2010). BF0801, a novel adenine derivative, inhibits platelet activation via phosphodiesterase inhibition and P2Y12 antagonism. Thrombosis and Haemostasis. 104(10). 845–857. 26 indexed citations

18.

Ding, Zhongren, Soochong Kim, & Satya P. Kunapuli. (2005). Identification of a Potent Inverse Agonist at a Constitutively Active Mutant of Human P2Y12 Receptor. Molecular Pharmacology. 69(1). 338–345. 23 indexed citations

19.

Ding, Zhongren & Jiaqi Pan. (2004). Distribution of PAI-1 promoter 4G/5G polymorphism in healthy Chinese and functional characterization using a luciferase reporter vector. Annals of Hematology. 84(3). 183–187. 7 indexed citations

20.

Ding, Zhongren, et al.. (2004). Arg333 and Arg334 in the COOH terminus of the human P2Y₁ receptor are crucial for G_q coupling. American Journal of Physiology-Cell Physiology. 288(3). C559–C567. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact